West Pharmaceutical Services WST
NYSE WST
$364.80 -5.96 (-1.61%)
As of: Oct 1, 2026 · 3:59 PM EDT

West Pharmaceutical Services (WST) Gross Profit (2009 - 2026)

Updated

West Pharmaceutical Services' Gross Profit came in at $329.2 million for Q2 2026, up 20.2% from $273.9 million a year earlier and up 11.1% from the prior quarter.

Analysis

West Pharmaceutical Services (WST) Gross Profit (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, West Pharmaceutical Services reported Gross Profit of $1.22 billion, up 17.2% year-over-year; for FY2025, it came in at $1.1 billion, up 10.6% from FY2024.

  • Gross Profit carries a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
  • Going back by year, Gross Profit was $998.5 million in FY2024 (-11.6%), $1.13 billion in FY2023 (-0.6%), $1.14 billion in FY2022 (-3.4%) and $1.18 billion in FY2021 (+53.1%).
  • The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q2 2009.
  • Year-over-year, Gross Profit has increased for six consecutive quarters, with growth averaging 10.0% over the last eight quarters.
  • The fastest year-over-year change in Gross Profit over five years came in Q3 2021 (growth of 48.1%), and the weakest in Q2 2024 (a decline of 21.1%).
  • Business Quant data shows WST's Gross Profit at $296.4 million (Q1 2026), $303.9 million (Q4 2025) and $294.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

West Pharmaceutical Services Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=WST&period=max&api_key=YOUR_API_KEY